Kei Takehara

Dr. Kei Takehara

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2024 in Medicina
Verified
Journal Article
Open access
PDF file
NHNobuhiro Hirasawa
Nobuhiro Hirasawa
YSYukiyo Shimizu
Yukiyo Shimizu
AHAyumu Haginoya
Ayumu Haginoya
YSYuichiro Soma
Yuichiro Soma
GWGaku Watanabe
Gaku Watanabe
YHYasushi Hada
Yasushi Hada
Background and Objectives: Bedridden patients are at a high risk of venous thromboembolism (VTE). Passive devices such as elastic compression stockings and intermittent pneumatic compression are common. Leg exercise apparatus (LEX) is an active device designed to prevent VTE by effectively contracting the soleus muscle and is therefore expected to be effective in preventing disuse of the lower limbs. However, few studies have been conducted on the kinematic properties of LEX. Therefore, this study aimed to compare the exercise characteristics of LEX with those of an ergometer, which is commonly used as a lower-limb exercise device, and examine its effect on the two domains of muscle activity and circulatory dynamics. Materials and Methods: This study used a crossover design in which each participant performed both exercises to evaluate the exercise characteristics of each device. Fifteen healthy adults performed exercises with LEX and an ergometer (Terasu Erugo, SDG Co., Ltd., Tokyo, Japan) for 5 min each and rested for 10 min after each exercise. Muscle activity was measured using surface electromyography (Clinical DTS, Noraxon, Scottsdale, AZ, USA), and circulatory dynamics were recorded using a non-invasive impedance cardiac output meter (Physioflow Enduro, Manatec Biomedical, Paris, France). The primary outcome was the mean percentage of maximum voluntary contraction (%MVC) of the soleus muscle during exercise. Results: The mean %MVC of the soleus muscle was significantly higher in the LEX group, whereas no significant differences were observed across the periods and sequences. Heart rate, stroke volume, and cardiac output increased during exercise and decreased thereafter; however, the differences between the devices were not significant. Conclusions: LEX may not only have a higher thromboprophylaxis effect, but also a higher effect on preventing muscle atrophy as a lower-extremity exercise device. Additionally, LEX could potentially be used safely in patients who need to be monitored for changes in circulatory dynamics.

1 January 2022 in Acute Medicine & Surgery
Verified
Journal Article
Open access
PDF file
KTKei Takehara
Kei Takehara
MMMichiko Mizobe
Michiko Mizobe
KEKeita Endo
Keita Endo
AMAkihiro Miyake
Akihiro Miyake
TSToshihiko Suzuki
Toshihiko Suzuki
HFHiraku Funakoshi
Hiraku Funakoshi
Background: We report a case of acute renal failure with loin pain and patchy renal ischemia after anaerobic exercise (ALPE) caused by sudden training resumption.Case presentation: A 19‐year‐old Asian man who was a college American football player presented with severe back pain, headache, and malaise. He developed acute kidney injury without myoglobinuria. Based on the typical medical history and symptoms, we made a diagnosis of ALPE. Symptoms improved within a few days, and serum creatinine levels improved after discharge. He resumed training, adjusting his load step by step.Conclusion: During the coronavirus disease 2019 pandemic, many athletes were unable to undergo adequate training. Long‐term de‐training leads to decreased various organ function and reduces the anaerobic threshold. Rapid resumption after prolonged de‐training may put individuals at risk of developing ALPE.


1 January 2023 in Acute Medicine & Surgery
Verified
Journal Article
Open access
TSTomoyuki Shirahige
Tomoyuki Shirahige
YMYusuke Miwa
Yusuke Miwa
KTKei Takehara
Kei Takehara
KSKana Sawada
Kana Sawada
HFHiraku Funakoshi
Hiraku Funakoshi

9 September 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
GWGaku Watanabe
Gaku Watanabe
YSYukiyo Shimizu
Yukiyo Shimizu
KTKei Takehara
Kei Takehara
YMYuki Mataki
Yuki Mataki
SKShigeki Kubota
Shigeki Kubota
YHYasushi Hada
Yasushi Hada
Background/Objectives: The Synchronized Hand Interface for Neurorehabilitation and Innovation (SHINI) is a mechanical device that uses voluntary movement of the unaffected or less affected upper limb to generate synchronized bilateral hand and finger movements without biological signal detection or electronic control. This exploratory study evaluated SHINI’s technical operability and practical limitations during a single supervised session. Methods: Seven participants with hand dysfunction of varied etiologies attempted one 10 min session. Completion status was categorized as completed without therapist intervention, completed with therapist intervention, or not completed; no quantitative acceptability threshold was prespecified. Secondary outcomes were adverse events, overall perceived exertion and upper-limb fatigue assessed using the modified Borg Scale, exploratory pre- and post-session modified Ashworth Scale scores, and participant and therapist feedback. Results: Three participants (42.9%) completed the session without therapist intervention, three (42.9%) completed it with therapist intervention, and one (14.3%) did not complete it. Hand or forearm displacement affected four participants (57.1%), including the participant who discontinued. No adverse events occurred. Perceived exertion and upper-limb fatigue were generally low, no consistent direction of change in modified Ashworth Scale scores was observed, and feedback emphasized the need for improved fixation and adjustability. Conclusions: SHINI showed preliminary technical operability during a single supervised session, but the findings do not establish feasibility for independent or semi-supervised use. With improved fixation and adaptability, SHINI may offer a simple mechanical approach to repetitive bilateral hand training. Repeated-use studies are required to evaluate usability, safety, and clinical effectiveness.

18 August 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
KTKei Takehara
Kei Takehara
YSYukiyo Shimizu
Yukiyo Shimizu
HKHideki Kadone
Hideki Kadone
GWGaku Watanabe
Gaku Watanabe
YSYuichiro Soma
Yuichiro Soma
YHYasushi Hada
Yasushi Hada
Repeated sit-to-stand practice is an important rehabilitation strategy for individuals with trunk and lower limb impairments; however, its implementation is often limited by fall risk, patient fatigue, and the physical burden on assisting staff. This prospective single-center feasibility study evaluated the safety and feasibility of sit-to-stand training using Qolo, a motor-free, gas-spring-assisted sit-to-stand training device, in 40 clinically selected individuals with trunk and lower limb impairments. All sessions were performed under physiatrist supervision. The primary feasibility endpoint was completion of at least three intervention sessions using Qolo. A total of 181 sessions were conducted, and in this clinically selected, supervised cohort, 36 participants achieved the primary endpoint, yielding a feasibility rate of 90.0% (95% confidence interval, 76.9–96.0%). The median number of sessions was 4 per participant, with 48 sit-to-stand repetitions per session and 134 repetitions per participant. Participant-reported fatigue was descriptively higher after training, whereas perceived fatigue among primary assisting staff remained low. No intervention-related adverse events, falls, or skin injuries were observed in this supervised feasibility study. Thirteen device-related problems were recorded, most of which involved the Qolo–tablet connection rather than the assistive mechanism, indicating important usability and reliability issues for further refinement. These findings support the early feasibility of Qolo-assisted sit-to-stand training in this small, clinically selected, supervised, heterogeneous cohort. Further controlled studies are warranted to evaluate clinical effectiveness, sustained adherence, staff workload, device reliability, and safety under routine clinical use.